Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Jaguar Health (JAGX) Return on Sales (2016 - 2025)

Historic Return on Sales for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to 3.13%.

  • Jaguar Health's Return on Sales rose 900.0% to 3.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.48%, marking a year-over-year increase of 1700.0%. This contributed to the annual value of 3.36% for FY2024, which is 9300.0% up from last year.
  • According to the latest figures from Q3 2025, Jaguar Health's Return on Sales is 3.13%, which was up 900.0% from 3.54% recorded in Q2 2025.
  • In the past 5 years, Jaguar Health's Return on Sales registered a high of 2.53% during Q4 2022, and its lowest value of 36.57% during Q2 2021.
  • Moreover, its 5-year median value for Return on Sales was 4.0% (2022), whereas its average is 6.95%.
  • Its Return on Sales has fluctuated over the past 5 years, first tumbled by -336600bps in 2021, then soared by 333600bps in 2022.
  • Over the past 5 years, Jaguar Health's Return on Sales (Quarter) stood at 6.88% in 2021, then surged by 63bps to 2.53% in 2022, then tumbled by -60bps to 4.05% in 2023, then increased by 28bps to 2.92% in 2024, then fell by -7bps to 3.13% in 2025.
  • Its Return on Sales was 3.13% in Q3 2025, compared to 3.54% in Q2 2025 and 4.79% in Q1 2025.